Cargando…

A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer

Detalles Bibliográficos
Autores principales:	Guo, Yuchen, Zhou, Yangyang, Qin, Wenxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832958/ https://www.ncbi.nlm.nih.gov/pubmed/34708999 http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0520

Ejemplares similares

Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance
por: Lu, Yonggang, et al.
Publicado: (2021)

Correction: Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance
por: Lu, Yonggang, et al.
Publicado: (2022)

Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib
por: Wang, Jinfeng, et al.
Publicado: (2023)

Genome-Wide CRISPR/Cas9 Library Screening Identified that DUSP4 Deficiency Induces Lenvatinib Resistance in Hepatocellular Carcinoma
por: Huang, Shanzhou, et al.
Publicado: (2022)

CRISPR/Cas9 genome-wide screening identifies KEAP1 as a sorafenib, lenvatinib, and regorafenib sensitivity gene in hepatocellular carcinoma
por: Zheng, Adi, et al.
Publicado: (2019)

CRISPR/Cas9-based liver-derived reporter cells for screening of mPGES-1 inhibitors
por: Chen, Zhanfei, et al.
Publicado: (2019)

Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma
por: Mei, Jie, et al.
Publicado: (2021)

GenomeCRISPR - a database for high-throughput CRISPR/Cas9 screens
por: Rauscher, Benedikt, et al.
Publicado: (2017)

Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9
por: Barkau, Christopher L., et al.
Publicado: (2019)

Genome-wide CRISPR-Cas9 screens identify mechanisms of BET bromodomain inhibitor sensitivity
por: Estoppey, David, et al.
Publicado: (2021)

Orthologous CRISPR-Cas9 enzymes for Combinatorial Genetic Screens
por: Najm, Fadi J, et al.
Publicado: (2017)

CRISPR/Cas9 screening using unique molecular identifiers
por: Schmierer, Bernhard, et al.
Publicado: (2017)

JACKS: joint analysis of CRISPR/Cas9 knockout screens
por: Allen, Felicity, et al.
Publicado: (2019)

CRISPR/Cas9-based genome-wide screening of Dictyostelium
por: Ogasawara, Takanori, et al.
Publicado: (2022)

Applying CRISPR-Cas9 screens to dissect hematological malignancies
por: Iyer, Deepak Narayanan, et al.
Publicado: (2022)

Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes
por: Watters, Kyle E., et al.
Publicado: (2020)

Enhanced genome editing efficiency of CRISPR PLUS: Cas9 chimeric fusion proteins
por: Park, Jongjin, et al.
Publicado: (2021)

Using CRISPR/Cas9 to model human liver disease
por: Alves-Bezerra, Michele, et al.
Publicado: (2019)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

Sorafenib, Lenvatinib, or Lenvatinib Combining PD-1 Inhibitors Plus TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Analysis
por: Zhao, Shu, et al.
Publicado: (2022)

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)

CRISPR/Cas9-mediated gene targeting in Arabidopsis using sequential transformation
por: Miki, Daisuke, et al.
Publicado: (2018)

A simple and cost-effective method for screening of CRISPR/Cas9-induced homozygous/biallelic mutants
por: Guo, Jinggong, et al.
Publicado: (2018)

Increasing the performance of pooled CRISPR–Cas9 drop-out screening
por: Cross, Benedict C. S., et al.
Publicado: (2016)

An Efficient Visual Screen for CRISPR/Cas9 Activity in Arabidopsis thaliana
por: Hahn, Florian, et al.
Publicado: (2017)

Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities
por: Sanson, Kendall R., et al.
Publicado: (2018)

Systematic comparison of CRISPR-Cas9 and RNAi screens for essential genes
por: Morgens, David W, et al.
Publicado: (2016)

Analysis of CRISPR‐Cas9 screens identifies genetic dependencies in melanoma
por: Christodoulou, Eirini, et al.
Publicado: (2020)

Efficient CRISPR/Cas9 mutagenesis for neurobehavioral screening in adult zebrafish
por: Klatt Shaw, Dana, et al.
Publicado: (2021)

Targeting cellular mRNAs translation by CRISPR-Cas9
por: Liu, Yuchen, et al.
Publicado: (2016)

The effect of histone deacetylase inhibitors on the efficiency of the CRISPR/Cas9 system
por: Björnson, Ymer, et al.
Publicado: (2023)

Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance
por: Bowden, Anne Ramsay, et al.
Publicado: (2020)

Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9
por: Feng, Yan, et al.
Publicado: (2016)

A functional CRISPR/Cas9 screen identifies kinases that modulate FGFR inhibitor response in gastric cancer
por: Chen, Jiamin, et al.
Publicado: (2019)

CRISPR/Cas9 in Gastrointestinal Malignancies
por: Jefremow, André, et al.
Publicado: (2021)

Efficient Screening of CRISPR/Cas9-Induced Events in Drosophila Using a Co-CRISPR Strategy
por: Kane, Nanci S., et al.
Publicado: (2016)

ShrinkCRISPR: a flexible method for differential fitness analysis of CRISPR-Cas9 screen data
por: Tissier, Renaud L. M., et al.
Publicado: (2023)

Genome-Wide CRISPR-Cas9 Screen Identifies SMCHD1 as a Restriction Factor for Herpesviruses
por: Tian, Xuezhang, et al.
Publicado: (2023)

Microfluidic Cell Deformability Assay for Rapid and Efficient Kinase Screening with the CRISPR‐Cas9 System
por: Han, Xin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_68r1n6ppai8cof6d7q9tio6e0o